Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection
Status:
Terminated
Trial end date:
2020-06-04
Target enrollment:
Participant gender:
Summary
This is a prospective, double-blind, randomized, placebo-controlled study in two distinct
cohorts to evaluate the efficacy and safety of hydroxychloroquine in the prevention of
COVID-19 infection.